Oxacillin (Bactocill) is penicillinase-resistant penicillin (beta-lactam antibiotic) used in the treatment of susceptible gram-positive infections.
Oxacillin Uses:
-
Staphylococcal infections:
- Used for treatment of infections caused by penicillinase-producing staphylococci that have demonstrated susceptibility to the drug.
- In suspected cases of resistant staphylococcal infections, empiric therapy.
-
Limitations of use:
- Oxacillin should not be used in infections caused by organisms susceptible to penicillin G. Use
-
Off-Label:
- Adult Catheter-related bloodstream infections.
- Skin and soft tissue necrotizing infections.
- Surgical site infections.
Oxacillin Dose in Adults
Note:
- May have a significant amount of sodium.
- Consult product-specific labeling for the amount.
Oxacillin Dose in the treatment of Catheter-related bloodstream infections (off-label use):
- IV:
- 2 g after every 4 hours (Mermel 2009)
Oxacillin Dose in the treatment of Endocarditis:
-
Methicillin-susceptible Staphylococcus aureus (MSSA) (off-label dose; AHA [Baddour 2015]):
-
IV:
-
Native valve endocarditis:
- For 6 weeks, 12 g per day in 4 or 6 divided doses (ie, 2 g every 4 hours or 3 g every 6 hours).
- Note:
- Dosing intended for complicated right-sided infective endocarditis (IE) or left-sided IE.
- 2 weeks of therapy may be adequate, for uncomplicated right-sided IE.
-
Prosthetic valve endocarditis:
- For at least 6 weeks, 12 g per day in 6 divided doses (ie, 2 g every 4 hours) (use with rifampin for the entire course and gentamicin for first 2 weeks)
-
Oxacillin Dose in the treatment of Meningitis, bacterial: Methicillin-susceptible S. aureus: (off-label dose):
-
IV:
- 2 g every 4 hours.
- If the organism is susceptible and prosthetic material is present, consider the addition of rifampin.
Oxacillin Dose in the treatment of Osteomyelitis, native vertebral (off-label dose):
-
Staphylococcus (oxacillin-susceptible):
- IV:
- For 6 weeks, 1.5-2 g every 4-6 hours or via continuous infusion.
Oxacillin Dose in the treatment of prosthetic joint infection:
- IV:
- With rifampin, 2 g every 4 hours
Dose in the treatment of methicillin-susceptible Staphylococcus aureus infections:
- Including
- brain abscess,
- bursitis,
- erysipelas,
- mastitis,
- mastoiditis,
- osteomyelitis,
- perinephric abscess,
- pneumonia,
- pyomyositis,
- scalded skin syndrome, and
- toxic shock syndrome:
- IV:
- 2 g every 4 hours
Oxacillin Dose in the treatment of Skin and soft tissue infections:
IV:
-
Due to methicillin-susceptible Staphylococcus aureus (MSSA):
- For 7 to 14 days, 1 to 2 g every 4 hours
Oxacillin Dose in the treatment of Necrotizing infection due to MSSA (off-label):
- Every 4 hours, 1 to 2 g
- Until further debridement is not necessary, continue, the patient has clinically improved, and the patient is afebrile for 48-72 hours
Oxacillin Dose in the treatment of Surgical site infections (trunk or extremity away from axilla or perineum) (off-label):
- IV:
- 2 g every 6 hours (IDSA [Stevens 2014])
Oxacillin Dose in Childrens
Oxacillin General dosing in susceptible infection:
-
Mild to moderate infections:
- Infants, Children, and Adolescents IM/ IV:
- Every 6 hours, 100-150 mg/kg/day in divided doses.
- Max daily dose: 4,000 mg per day
- Infants, Children, and Adolescents IM/ IV:
-
Severe infections:
- Infants, Children, and Adolescents (IM//IV):
- Every 4 to 6 hours, 150-200 mg/kg/day in divided doses.
- Max daily dose:
- 12 g per day
- Infants, Children, and Adolescents (IM//IV):
Oxacillin Dose in the treatment of Endocarditis:
-
Children and Adolescents (IV):
- Every 4 to 6 hours, 200 mg/kg/day in divided doses.
- Max daily dose:
- 12 g per day.
- Treat for at least four weeks.
- Extended durations may be needed.
- May use in combination with gentamicin for some resistant organisms.
Oxacillin Dose in the treatment of Meningitis and Ventriculitis:
-
Infants, Children, and Adolescents (IV):
- Every 6 hours, 200 mg/kg/day in divided doses.
- Max daily dose:
- 12 g per day (IDSA [Tunkel 2004]; IDSA [Tunkel 2017])
Oxacillin Dose in the treatment of community-acquired (CAP) moderate to severe infection S. aureus (methicillin-susceptible) Pneumonia:
-
Infants >3 months, Children, and Adolescents (IV):
- Every 6 to 8 hours, 150-200 mg/kg/day divided (IDSA/PIDS [Bradley 2011])
Oxacillin Dose in the treatment of Skin and soft tissue infections:
-
Infants, Children, and Adolescents:
-
Methicillin-susceptible Staphylococcus aureus (MSSA) IV:
- Every 6 hours, 100-150 mg/kg/day in divided doses.
- Max daily dose:
- 12 g per day
-
Necrotizing infection due to MSSA (IV):
- Every 6 hours, 200 mg/kg/day in divided doses.
- Max daily dose:
- 12 g per day.
- Continue until further debridement is not necessary, the patient has clinically improved, and the patient is afebrile for 48-72 hours.
-
Oxacillin Pregnancy risk Category: B
- Oxacillin is absorbed into the amniotic fluid and detected in cord blood.
- Penicillin use by mothers has not been linked to an increase in the risk of adverse effects on fetal health.
Use of Oxacillin while breastfeeding
- Breast milk contains Oxacillin.
- The manufacturer suggests that nursing mothers be cautious when administering oxacillin.
- These effects may not be related to the dosage.
Oxacillin Dose in Kidney Disease:
- In the manufacturer's labeling, there are no dosage adjustments provided.
- However, if renal impairment is known or suspected, the manufacturer suggests considering a reduction in total dosage.
Oxacillin Dose in Liver Disease:
- In the manufacturer's labeling, there are no dosage adjustments provided.
Side effects of Oxacillin:
-
Gastrointestinal:
- Clostridioides Difficile Associated Diarrhea
- Clostridioides Difficile Colitis
-
Hepatic:
- Hepatotoxicity
- Increased Serum Aspartate Aminotransferase
-
Renal:
- Acute Interstitial Nephritis
- Acute Renal Tubular Disease
Contraindications to Oxacillin:
- Hypersensitivity (eg anaphylaxis), to any penicillin or any component of the formulation.
Warnings and precautions
-
Anaphylactic and hypersensitivity reactions
- Patients who have received penicillin therapy for severe and sometimes fatal hypersensitivity reactions (anaphylactic) have been diagnosed.
- This includes patients with a history beta-lactam hypersensitivity, multiple allergies history, or IgE-mediated reactions such as anaphylaxis (eg, angioedema, allergic urticaria).
- Patients with history of severe allergies or asthma should be cautious.
- Stop using the medication if you experience an allergic reaction and seek out appropriate treatment.
-
Hepatitis
- Acute hepatitis can sometimes be accompanied by leukopenia and rash. Reversible elevations in serum transaminases may also be reported.
- After 2-3 weeks of therapy, symptoms will begin to appear.
- Examine regularly during therapy.
-
Superinfection
- Extended use can lead to fungal or bacterial overinfections, such as C. difficile-associated diarrhea(CDAD) and pseudomembranous collitis.
- CDAD was observed for >2 months after antibiotic treatment.
-
Renal impairment
- Be careful.
- Recommendation to adjust dosage.
Oxacillin: Drug Interaction
|
Risk Factor C (Monitor therapy) |
|
|
Acemetacin |
May increase the serum concentration of Penicillins. |
|
BCG Vaccine (Immunization) |
Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). |
|
Lactobacillus and Estriol |
Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. |
|
Methotrexate |
Penicillins may increase the serum concentration of Methotrexate. |
|
Mycophenolate |
Penicillins may decrease serum concentrations of the active metabolite(s) of Mycophenolate. This effect appears to be the result of impaired enterohepatic recirculation. |
|
Probenecid |
May increase the serum concentration of Penicillins. |
|
Vitamin K Antagonists (eg, warfarin) |
Penicillins may enhance the anticoagulant effect of Vitamin K Antagonists. |
|
Risk Factor D (Consider therapy modification) |
|
|
Sodium Picosulfate |
Antibiotics may diminish the therapeutic effect of Sodium Picosulfate. Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic. |
|
Tetracyclines |
May diminish the therapeutic effect of Penicillins. |
|
Typhoid Vaccine |
Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected. Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents. Use of this vaccine should be postponed until at least 3 days after cessation of antibacterial agents. |
|
Risk Factor X (Avoid combination) |
|
|
BCG (Intravesical) |
Antibiotics may diminish the therapeutic effect of BCG (Intravesical). |
|
Cholera Vaccine |
Antibiotics may diminish the therapeutic effect of Cholera Vaccine. Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics. |
Monitoring Parameters:
- During the first dose, observe for signs and symptoms of anaphylaxis.
- Examine periodic CBC, urinalysis, BUN, serum creatinine, AST and ALT,
How to administer Oxacillin?
IV:
- Administer IVP over 10 mins or IVPB (IV piggyback) over 30 mins.
Mechanism of action of Oxacillin:
- One or more penicillin-binding protein (PBPs) inhibits bacterial cell cell wall synthesis by binding.
- This in turn inhibits the final step of peptidoglycan transpeptidation in bacterial cells walls and thus, inhibits cell wall biosynthesis.
- Despite the fact that cell wall assembly is stopped, bacteria eventually lyses due to the ongoing activity of cell-wall autolytic enzymes (autolysins and murein hydrolases).
Distribution:
- Into bile, amniotic, and pleural fluids.
- In CSF and aqueous humor, insignificant concentrations
Protein binding:
- ~94 percent (mainly albumin)
Metabolism:
- Hepatic
Half-life elimination:
- Neonates (PNA: 8-15 days):
- 1.6 hours
- Infants and Children ≤2 years:
- 0.9-1.8 hours
- Adults:
- 20-30 mins.
- Prolonged with renal impairment
Time to peak serum concentration:
- IM:
- 30 mins
- IV:
- 5 mins
Excretion:
- Urine and bile (unchanged drug)
International Brands of Oxacillin:
- Bactocill in Dextrose
- Biotam
- Bristopen
- Cloxacap
- Cloxcin
- Minzil
- Ocillina
- Ocina
- Oxacilina
- Oxacillin
- Oxan
- Oxanon
- Oxapen
- Oxatalis
- Penstapho
- Procillin
- Prostafilina
- Prostaphlin
- Stapenor
- Syntarpen
- Wydox
Oxacillin Brand Names in Pakistan:
No Brands Available in Pakistan.